We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalent Biologics Expands into ADCs through Exclusive License with Redwood Bioscience

News   Apr 11, 2013

 
Catalent Biologics Expands into ADCs through Exclusive License with Redwood Bioscience
 
 
 

RELATED ARTICLES

Fire, Sun or Electricity Powers Hand-held Cancer Detection Device

News

Device shows promise as a point-of-care detector of Kaposi sarcoma-associated herpesvirus in resource-limited settings.

READ MORE

Clinical Prospects for Stem Cells Begin to Emerge

News

There is now a critical mass of experts in this field and things are moving much faster, Stanford scientists say.

READ MORE

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE